Disease Models and Translational Research
Our cutting-edge neurological and CNS research services provide a multifaceted approach to assessment of neurological diseases. Our facilities are fitted with state-of-the-art equipment and technologies for preclinical and translational studies, featuring clinically-relevant read outs and endpoints. These are further complimented by our in house histology, biomarker and electrophysiology capabilities including the Neurometer® CPT® (Neurotron, Inc.), a unique neurodiagnostic device that painlessly evaluates the functioning of small unmyelinated (C), small myelinated (Aδ) and large myelinated (Aβ) sensory nerve fibers at any cutaneous site. The Neurometer® CPT® is sensitive to both hypoesthetic and hyperesthetic abnormalities, and has more than 800 peer reviewed research publications documenting its clinical diagnostic capabilities. Finally, our unique pig translational models share a high degree of similarity to humans thus offering greater clinical efficacy serve to augment and accelerate your program towards their next objectives and milestones.
As a leader in the study of neuropathic, acute and chronic pain, MD Biosciences offers multiple validated models and relevant pain read-outs. Other specializations in neurodegenerative diseases include Parkinson's, neuro-inflammatory diseases such as Multiple Sclerosis (MS), and capabilities in stroke and cerebral ischemia. Contact us to learn more about customizable offerings. Check out our publications in Pain!
MD Biosciences Pain Publications
Check out our behavioral assessments and capabilities to combine with physiological readouts to offer a more comprehensive understanding of disease mechanisms and therapeutic application.